on O3 Holding GmbH (isin : NO0013360552)
O3 Holding GmbH Releases Q2 2026 Interim Report
O3 Holding GmbH, the holding company behind KD Pharma Group, has published its Q2 2026 Interim Report. This update is aligned with the bond requirements for the Company's FRN Senior Secured EUR 180 million bond issue. The bond, carrying ISIN NO0013360552, was initially issued on October 28, 2024. Investors and interested parties can access the detailed financial report on the Company’s official website.
The KD Pharma Group is recognized for its leadership in the contract development and manufacturing organization (CDMO) sector, particularly within the pharmaceutical and nutritional lipid spaces. This latest report forms a crucial part of the Company's commitment to transparency with its stakeholders.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all O3 Holding GmbH news